- News & Analysis
- Home
- Global Corporate Venturing
- Global University Venturing
- Latest News
- Publications
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- Video
- Subscribe
- Newsletters
- Events
Page 48
Comet soars to $13m series A
Alexa Fund-backed MLOps technology developer Comet has now raised more than $19m altogether, Scale Venture Partners having led its latest round.
Apr 9, 2021Metagenomi magnifies series A to $75m
The DNA-editing technology developer has raised $10m in addition to the $65m it pulled in from investors including Leaps by Bayer in November.
Apr 8, 2021Allm calls in $50m in series A
Capital Medica, Cyberdyne, Eisai, Financial Agency, Mitsui, Mixi, Opt, NID, Philips, Sompo and Vector all took part in a round for the medical ICT tool developer.
Apr 7, 2021Axera finds Legend Star in series A
Legend Holdings subsidiary Legend Star helped the computer vision technology developer raise an eight-figure dollar amount in pre-series A and series A rounds.
Apr 7, 2021Bartesian tops up funding with $20m
Stanley Ventures participated in a series A round for Bartesian, which has created an intelligent cocktail maker and which is backed by Beam Suntory.
Apr 7, 2021Flash Coffee heats up with $15m
Delivery Hero's DX Partners was among the investors in a series A round that will support the coffee retailer's Asian expansion.
Apr 7, 2021Guardian Agriculture takes off with series A
The drone-based crop analysis system developer secured $10.5m in a round led by Leaps by Bayer that also featured Cavallo Ventures and FMC Ventures.
Apr 7, 2021Corporate venturing deal net: 29 March-1 April 2021
Each week the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Apr 1, 2021Outpace Bio chases down $30m
Lyell Immunopharma co-led a series A round for the gene therapy developer, which was spun off by the corporate's co-founders.
Apr 1, 2021Qihan Biotech quickens pace to $67m
Lilly Asia Ventures participated in a series A-plus-plus round pushing the genome editing technology developer's total funding past $100m.
Apr 1, 2021
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.